Neuroendocrine cancer uk. DR. EUGENIU BANU, MEDIC PRIMAR ONCOLOGIE MEDICALA
Recurrent left bockdalek hernia in adult, a rare cause of subocclusive syndrome.
Neuroendocrine cancer diagnosis. Neuroendocrine cancer a
Chirurgia Bucur. Gastric metastasis of cervix uteri carcinoma, rare cause of lower gastric stenosis.
Understanding your Neuroendocrine Cancer Diagnosis
A phase II study of the cancer vaccine TG alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings. Cancer Immunol Immunother Feb;60 2 Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.
Radiology Aug; 2 Epub Jun What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated neuroendocrine cancer uk docetaxel? BJU Int Jun; 12 Epub Feb 6.
Prostate-specific antigen kinetics in localized and advanced prostate cancer. BJU Int Mar; 5 Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case series. Eur Urol Jul;56 1quiz Epub Jan Therapeutic strategy for treatment of metastatic non-small cell lung cancer.
Ann Pharmacother Nov;42 11 Oct Epub Oct Multiple lung cancers prognosis: what about histology?
Ann Thorac Surg Sep;86 3 Platelet microparticles: a potential predictive factor of survival in hormone-refractory prostate cancer patients treated with docetaxel-based chemotherapy. Eur Urol Sep;56 3 ;, Epub Jun Ann Thorac Surg ;86 1 Strategies and outcomes in pulmonary and extrapulmonary metastases from renal cell cancer.
Eur J Cardiothorac Surg May;33 5 Epub Mar 4. Matched case-control phase 2 study to evaluate the use of a frozen sock to prevent docetaxel-induced onycholysis and cutaneous toxicity of the foot.
Fișier:Diagram showing the position of the pancreas CRUK 356.svg
Cancer Apr; 7 Epub Feb Chemotherapy for prostate cancer. Presse Med May; 37 5 Pt 2 Epub Dec Completely resected non-small cell lung cancer: reconsidering prognostic value and significance of N2 metastases.
Ann Thorac Surg Dec;84 6 Drugs Aging ;24 10 Prostate-specific antigen neuroendocrine cancer uk time before onset of chemotherapy as survival predictor for hormone-refractory prostate cancer patients.
Ann Oncol Nov;18 11 Epub Sep 9.
Serum PSA half-life as a predictor of survival of hormone-refractory prostate cancer patients: Modelization using a standardised set of response criteria. Prostate Oct;67 14 Reversible encephalopathy syndrome secondary to sunitinib for metastatic renal cell carcinoma patient. Targeted Oncology Jul;2 3 New targeted therapies in hormone-refractory prostate cancer.
Prospective multicenter phase II study of Gemcitabine plus platinum salt for metastatic collecting duct carcinoma neuroendocrine cancer uk. J Urol May; Oudard, J. Medioni, A. Chedid, E.
Banu, D. Dionysopoulos, J. Balcaceres, F.
- Examenul clinic in ortopedie.
- Cancer de colon la batrani
Toxicity of antiangiogenic bevacizumab, sunitinib, sorafenib : summary and clinical practice management. Prostate cancer: update.
- Human papillomavirus rash description.
- Cancer colon drept simptome
Bull Cancer Oct;92 10 A multicenter study to evaluate the use of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand. J Clin Oncol Jul;23 19 Multicenter randomized phase II study of two schedules of docetaxel, estramustine, and prednisone versus mitoxantrone plus prednisone in patients with metastatic hormone-refractory prostate cancer.
J Clin Oncol May;23 15 Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol May;63 1